Granzymes A and B serum levels in allo-SCT

B Kircher1, P Schumacher, D Nachbaur

  • 1Department of Internal Medicine V-Hematology and Oncology, Immunobiology and Stem Cell Laboratory, Innsbruck Medical University, Innsbruck, Austria. brigitte.kircher@i-med.ac.at

Bone Marrow Transplantation
|December 17, 2008
PubMed
Summary

Elevated granzyme (Gr) levels in patients undergoing allogeneic stem cell transplant (Allo-SCT) can predict serious complications like graft-versus-host disease (GVHD) and cytomegalovirus (CMV) infection. Monitoring GrA and GrB serum levels offers a valuable predictive tool for post-transplant outcomes.

Related Concept Videos